Medclair AB Statistics

Total Valuation

Medclair AB has a market cap or net worth of SEK 148.07 million. The enterprise value is 138.26 million.

Market Cap	148.07M
Enterprise Value	138.26M

Important Dates

The next estimated earnings date is Friday, November 1, 2024.

Earnings Date	Nov 1, 2024
Ex-Dividend Date	n/a

Share Statistics

Medclair AB has 82.49 million shares outstanding. The number of shares has increased by 29.08% in one year.

Shares Outstanding	82.49M
Shares Change (YoY)	+29.08%
Shares Change (QoQ)	-3.58%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

The trailing PE ratio is 70.40.

PE Ratio	70.40
Forward PE	n/a
PS Ratio	3.41
PB Ratio	2.77
P/FCF Ratio	17.61
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 73.04, with an EV/FCF ratio of 16.44.

EV / Earnings	56.80
EV / Sales	2.75
EV / EBITDA	73.04
EV / EBIT	n/a
EV / FCF	16.44

Financial Position

The company has a current ratio of 1.88, with a Debt / Equity ratio of 0.27.

Current Ratio	1.88
Quick Ratio	1.40
Debt / Equity	0.27
Debt / EBITDA	0.08
Debt / FCF	0.02
Interest Coverage	-7.44

Financial Efficiency

Return on equity (ROE) is 4.64% and return on invested capital (ROIC) is -3.21%.

Return on Equity (ROE)	4.64%
Return on Assets (ROA)	-2.70%
Return on Capital (ROIC)	-3.21%
Revenue Per Employee	3.59M
Profits Per Employee	173,857
Employee Count	14
Asset Turnover	0.80
Inventory Turnover	2.30

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +46.89% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+46.89%
50-Day Moving Average	1.64
200-Day Moving Average	1.44
Relative Strength Index (RSI)	48.87
Average Volume (20 Days)	879,329

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Medclair AB had revenue of SEK 50.30 million and earned 2.43 million in profits. Earnings per share was 0.03.

Revenue	50.30M
Gross Profit	29.07M
Operating Income	-2.71M
Pretax Income	2.44M
Net Income	2.43M
EBITDA	1.89M
EBIT	-2.71M
Earnings Per Share (EPS)	0.03

Full Income Statement

Balance Sheet

The company has 9.96 million in cash and 143,000 in debt, giving a net cash position of 9.81 million or 0.12 per share.

Cash & Cash Equivalents	9.96M
Total Debt	143,000
Net Cash	9.81M
Net Cash Per Share	0.12
Equity (Book Value)	53.50M
Book Value Per Share	0.65
Working Capital	12.27M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 9.44 million and capital expenditures -1.03 million, giving a free cash flow of 8.41 million.

Operating Cash Flow	9.44M
Capital Expenditures	-1.03M
Free Cash Flow	8.41M
FCF Per Share	0.10

Full Cash Flow Statement

Margins

Gross margin is 57.79%, with operating and profit margins of -5.40% and 4.84%.

Gross Margin	57.79%
Operating Margin	-5.40%
Pretax Margin	4.86%
Profit Margin	4.84%
EBITDA Margin	3.76%
EBIT Margin	-5.40%
FCF Margin	16.72%

Dividends & Yields

Medclair AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-29.08%
Shareholder Yield	-29.08%
Earnings Yield	1.42%
FCF Yield	5.68%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a